Audio By Carbonatix
BioMex, in collaboration with the German Development Cooperation, has opened applications for the Cohort 2 BioMex Certificate Programme, a fully funded, internationally recognised upskilling programme.
Professionals, recent graduates and aspiring innovators in biotechnology, pharmaceutical sciences, health care and life sciences in Ghana are invited to take the next step in advancing their careers as applications close on July 10, 2026.
Delivered in collaboration with the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH’s Strengthening the Ghana Pharma Sector Focusing on Vaccine Production (PharmaVax Ghana), the BioMex Certificate Programme offers participants a unique opportunity to upskill through a flexible and tailor-made selection of 26 modules across 6 thematic competence clusters.
The programme allows individuals to select modules tailored to their professional goals and add to their existing skill set to get ahead in their careers.
The thematic clusters cover Biotechnology & Biomedicine, Pharmaceutical Chemistry & Pharmaceutical Technology, Innovation Management and Intercultural Cooperation, Facility, Energy and Environmental Management, Health Care and Smart Medical Technologies, as well as Compliance and Risk Assessment.
Successful applicants to the BioMex Certificate Programme will benefit from a fully funded participation model; an individual, tailor-made module selection aligned with career goals; an internationally recognised certificate and access to the international BioMex alumni network.
Interested candidates are encouraged to apply before the July 10 deadline. Application requirements include a CV, university degree, transcript of records with overall grade, grading scale, letter of motivation, and one letter of reference.
The BioMex Certificate Programme is working with the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH through the PharmaVax Ghana programme, which is co-funded by the European Union and the German Federal Ministry for Economic Cooperation and Development.
It is part of the Team Europe Initiative Manufacturing and Access to Vaccines, Medicines and Health Technologies in Africa (MAV+).
Further information and application details are available at:
Latest Stories
-
Édouard Mendy annonce sa retraite internationale avec le Sénégal
2 hours -
Lamine Yamal scores twice as Barcelona maintain perfect start
2 hours -
Haaland scores controversial winner for 10-man City at Man Utd
2 hours -
Ghana’s narcotics crisis deepens as drug seizures linked to country top US$1bn – Minority
3 hours -
CAF CC: Nations FC bow out after draw with FC Diarra in Accra
3 hours -
Kenyans dominate 2026 KGL Millennium Marathon as race champions mental health
3 hours -
Minority demands full-scale probe into Ghana’s alleged emergence as narcotics transit hub
3 hours -
NaCCA trains teachers to implement new Chinese language curriculum
4 hours -
Ghana, China deepen cooperation on galamsey and mining sector
4 hours -
JoyNews–Republic Bank Habitat Fair ends on a high note after 3 days of strong patronage, expert engagement
5 hours -
Emma Ofosua takes West African spoken word to three UK cities
5 hours -
Traditional artists will become more expensive because of AI – Aewura Arts
5 hours -
Clients would disappear after I finished their artworks – Aewura Arts recounts challenges
5 hours -
Turkish police detain dozens in raids on gay bars and homes of LGBTQ+ activists
5 hours -
Trump doubles down on united Ireland comments on day two of visit
5 hours